Skip to main content

Preparing the Endometrium to Maximize Success: The Dynamics of Artificial Cycles

  • Chapter
  • First Online:
Principles of Oocyte and Embryo Donation

Abstract

In vitro fertilization (IVF) was developed for women with diseased or absent Fallopian tubes. Rapidly however, the clinical successes witnessed in IVF opened in their wake the doors to the until-then uncharted realm of oocyte exchanges. Together with its variant for male factor infertility – intracytoplasmic sperm injection (ICSI) – IVF is now called the assisted reproductive technology (ART). Logically, therefore, we refer to oocyte donation – with either IVF or ICSI – as donor-egg ART (DE-ART).

Using donated oocytes for women whose ovaries have failed – in DE-ART – implied however that endometrial receptivity may be attained through the prescribed use of exogenous hormones. At the outset, at a time when results of general IVF were relatively meager, the need to rely solely on artificially prepared endometrium in recipients tarnished any prospect that DE-ART would be successful. Hence, the improbable and rapid unraveling that placed the results of DE-ART not only at par but most often above those of the corresponding regular ART programs was certainly a surprise

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril. 1987;47(6): 895–909.

    PubMed  CAS  Google Scholar 

  2. Sauer MV, Bustillo M, Rodi IA, Gorrill MJ, Buster JE. In-vivo blastocyst production and ovum yield among fertile women. Hum Reprod. 1987;2(8):701–3.

    PubMed  CAS  Google Scholar 

  3. Sauer MV, Paulson RJ, Macaso TM, Francis-Hernandez M, Lobo RA. Establishment of a nonanonymous donor oocyte program: preliminary experience at the University of Southern California. Fertil Steril. 1989;52(3):433–6.

    PubMed  CAS  Google Scholar 

  4. Zegers-Hochschild F, Fernandez E, Fabres C, et al. Pregnancy rate in an oocyte donation program. J Assist Reprod Genet. 1992;9(4):350–2.

    Article  PubMed  CAS  Google Scholar 

  5. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online. 2006;12(2):153–62.

    Article  PubMed  Google Scholar 

  6. de Ziegler D, Romoscanu I, Ventura P, Ibecheole V, Fondop JJ, de Candolle G. The uterus and in vitro fertilization. Clin Obstet Gynecol. 2006;49(1):93–116.

    Article  PubMed  Google Scholar 

  7. Rabinowitz R, Laufer N, Lewin A, et al. The value of ultrasonographic endometrial measurement in the prediction of pregnancy following in vitro fertilization. Fertil Steril. 1986;45(6):824–8.

    PubMed  CAS  Google Scholar 

  8. Navot D, Anderson TL, Droesch K, Scott RT, Kreiner D, Rosenwaks Z. Hormonal manipulation of endometrial maturation. J Clin Endocrinol Metab. 1989;68(4):801–7.

    Article  PubMed  CAS  Google Scholar 

  9. Navot D, Bergh PA, Williams M, et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab. 1991;72(2):408–14.

    Article  PubMed  CAS  Google Scholar 

  10. Fanchin R, De Ziegler D, Bergeron C, Righini C, Torrisi C, Frydman R. Transvaginal administration of progesterone. Obstet Gynecol. 1997;90(3):396–401.

    Article  PubMed  CAS  Google Scholar 

  11. Schmidt CL, de Ziegler D, Gagliardi CL, et al. Tra­nsfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP). Fertil Steril. 1989;52(4):609–16.

    PubMed  CAS  Google Scholar 

  12. Meldrum DR, Wisot A, Hamilton F, Gutlay-Yeo AL, Marr B, Huynh D. Artificial agonadism and hormone replacement for oocyte donation. Fertil Steril. 1989;52(3):509–11.

    PubMed  CAS  Google Scholar 

  13. Lelaidier C, de Ziegler D, Gaetano J, Hazout A, Fernandez H, Frydman R. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod. 1992;7(10):1353–6.

    PubMed  CAS  Google Scholar 

  14. Simon A, Hurwitz A, Zentner BS, Bdolah Y, Laufer N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod. 1998;13(10):2712–7.

    Article  PubMed  CAS  Google Scholar 

  15. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature. 1984;307(5947):174–5.

    Article  PubMed  CAS  Google Scholar 

  16. Navot D, Laufer N, Kopolovic J, et al. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med. 1986;314(13):806–11.

    Article  PubMed  CAS  Google Scholar 

  17. Rosenwaks Z, Veeck LL, Liu HC. Pregnancy following transfer of in vitro fertilized donated oocytes. Fertil Steril. 1986;45(3):417–20.

    PubMed  CAS  Google Scholar 

  18. Liu HC, Davis O, Berkeley A, Graf M, Rosenwaks Z. Late luteal estradiol patterns are a better prognosticator of pregnancy outcome than serial beta-human chorionic gonadotropin concentrations. Fertil Steril. 1991;56(3):421–6.

    PubMed  CAS  Google Scholar 

  19. de Ziegler D, Fanchin R, Freitas S, Bouchard P. The hormonal control of endometrial receptivity in egg donation and IVF: from a two to a multi-player senario. Acta Eur Fertil. 1993;24(4):147–53.

    PubMed  Google Scholar 

  20. de Ziegler D, Fanchin R, de Moustier B, Bulletti C. The hormonal control of endometrial receptivity: estrogen (E2) and progesterone. J Reprod Immunol. 1998;39(1–2):149–66.

    Article  PubMed  Google Scholar 

  21. Khan-Dawood FS, Goldsmith LT, Weiss G, Dawood MY. Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab. 1989;68(3):627–31.

    Article  PubMed  CAS  Google Scholar 

  22. Weiss G. The physiology of human relaxin. Contrib Gynecol Obstet. 1991;18:130–46.

    PubMed  CAS  Google Scholar 

  23. Haning Jr RV, Goldsmith LT, Seifer DB, et al. Relaxin secretion in in vitro fertilization pregnancies. Am J Obstet Gynecol. 1996;174(1 Pt 1):233–40.

    Article  PubMed  CAS  Google Scholar 

  24. de Ziegler D. Controversies in regards to oocyte donation. J Assist Reprod Genet. 1994;11(10):491–4.

    Article  PubMed  Google Scholar 

  25. Sauer MV, Paulson RJ. Human oocyte and preembryo donation: an evolving method for the treatment of infertility. Am J Obstet Gynecol. 1990;163(5 Pt 1):1421–4.

    PubMed  CAS  Google Scholar 

  26. Lei ZM, Rao CV, Ackerman DM, Day TG. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms. J Clin Endocrinol Metab. 1992;74(6):1236–41.

    Article  PubMed  CAS  Google Scholar 

  27. Ziecik AJ, Derecka K, Gawronska B, Stepien A, Bodek G. Nongonadal LH/hCG receptors in pig: functional importance and parallels to human. Semin Reprod Med. 2001;19(1):19–30.

    Article  PubMed  CAS  Google Scholar 

  28. Lelaidier C, de Ziegler D, Freitas S, Olivennes F, Hazout A, Frydman R. Endometrium preparation with exogenous estradiol and progesterone for the transfer of cryopreserved blastocysts. Fertil Steril. 1995;63(4): 919–21.

    PubMed  CAS  Google Scholar 

  29. de Ziegler D, Jaaskelainen AS, Brioschi PA, Fanchin R, Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod. 1998;13(3):561–4.

    Article  PubMed  Google Scholar 

  30. Simon A, Holzer H, Hurwitz A, et al. Comparison of cryopreservation outcome following intracytoplasmic sperm injection and conventional in vitro fertilization. J Assist Reprod Genet. 1998;15(7):431–7.

    Article  PubMed  CAS  Google Scholar 

  31. de Ziegler D, Brioschi PA, Benchaa C, et al. Programming ovulation in the menstrual cycle by a simple innovative approach: back to the future of assisted reproduction. Fertil Steril. 1999;72(1):77–82.

    Article  PubMed  Google Scholar 

  32. de Ziegler D, Bergeron C, Cornel C, et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab. 1992;74(2):322–31.

    Article  PubMed  Google Scholar 

  33. de Ziegler D, Cornel C, Bergeron C, Hazout A, Bouchard P, Frydman R. Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries. Fertil Steril. 1991;56(5):851–5.

    PubMed  Google Scholar 

  34. Fowler PA, Messinis IE, Cunningham P, Fraser M, Templeton AA. Effects of gonadotrophin surge-attenuating factor on the two pools of gonadotrophin-releasing hormone-induced luteinizing hormone secretion in vitro. Hum Reprod. 1993;8(6):822–8.

    PubMed  CAS  Google Scholar 

  35. de Ziegler D, Fanchin R. Progesterone and progestins: applications in gynecology. Steroids. 2000;65(10–11): 671–9.

    Article  PubMed  Google Scholar 

  36. de Ziegler D, Bouchard P. Understanding endometrial physiology and menstrual disorders in the 1990s. Curr Opin Obstet Gynecol. 1993;5(3):378–88.

    Article  PubMed  Google Scholar 

  37. Grunfeld L, Walker B, Bergh PA, Sandler B, Hofmann G, Navot D. High-resolution endovaginal ultrasonography of the endometrium: a noninvasive test for endometrial adequacy. Obstet Gynecol. 1991;78(2):200–4.

    PubMed  CAS  Google Scholar 

  38. Porter MB. Ultrasound in assisted reproductive technology. Semin Reprod Med. 2008;26(3):266–76.

    Article  PubMed  Google Scholar 

  39. Fanchin R, Righini C, Ayoubi JM, Olivennes F, de Ziegler D, Frydman R. New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril. 2000;74(2):274–81.

    Article  PubMed  CAS  Google Scholar 

  40. Evron A, Goldman S, Shalev E. Effect of primary human endometrial stromal cells on epithelial cell receptivity and protein expression is dependent on menstrual cycle stage. Hum Reprod. 2011;26(1): 176–90.

    Article  PubMed  CAS  Google Scholar 

  41. Ayoubi JM, Fanchin R, Kaddouz D, Frydman R, de Ziegler D. Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans. Fertil Steril. 2001;76(4):736–40.

    Article  PubMed  CAS  Google Scholar 

  42. Dressing GE, Goldberg JE, Charles NJ, Schwertfeger KL, Lange CA. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids. 2011;76(1–2):11–7.

    Article  PubMed  CAS  Google Scholar 

  43. Smith SS, Shen H, Gong QH, Zhou X. Neurosteroid regulation of GABA (A) receptors: focus on the alpha4 and delta subunits. Pharmacol Ther. 2007;116(1):58–76.

    Article  PubMed  CAS  Google Scholar 

  44. Noyes RW, Haman JO. Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses. Fertil Steril. 1953;4(6):504–17.

    PubMed  CAS  Google Scholar 

  45. Horcajadas JA, Sharkey AM, Catalano RD, et al. Effect of an intrauterine device on the gene expression profile of the endometrium. J Clin Endocrinol Metab. 2006;91(8):3199–207.

    Article  PubMed  CAS  Google Scholar 

  46. Horcajadas JA, Minguez P, Dopazo J, et al. Controlled ovarian stimulation induces a functional Genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab. 2008;93(11):4500–10.

    Article  PubMed  CAS  Google Scholar 

  47. Bellver J, Melo MA, Bosch E, Serra V, Remohi J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007;88(2):446–51.

    Article  PubMed  Google Scholar 

  48. Navot D, Scott RT, Droesch K, Veeck LL, Liu HC, Rosenwaks Z. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril. 1991;55(1):114–8.

    PubMed  CAS  Google Scholar 

  49. Klein J, Sauer MV. Oocyte donation. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):277–91.

    Article  PubMed  Google Scholar 

  50. Moomjy M, Cholst I, Mangieri R, Rosenwaks Z. Oocyte donation: insights into implantation. Fertil Steril. 1999;71(1):15–21.

    Article  PubMed  CAS  Google Scholar 

  51. Macklon NS, van der Gaast MH, Hamilton A, Fauser BC, Giudice LC. The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci. 2008;15(4):357–65.

    Article  PubMed  CAS  Google Scholar 

  52. Kort DH, Gosselin J, Choi JM, Thornton MH, Cleary-Goldman J, Sauer MV. Pregnancy after age 50: defining risks for mother and child. Am J Perinatol. 2012;29:245–50.

    Article  PubMed  Google Scholar 

  53. Anaf V, Simon P, El Nakadi I, et al. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15(8):1744–50.

    Article  PubMed  CAS  Google Scholar 

  54. Tokushige N, Markham R, Russell P, Fraser IS. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006;21(11):3001–7.

    Article  PubMed  CAS  Google Scholar 

  55. Tokushige N, Markham R, Russell P, Fraser IS. Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril. 2007;88(4):795–803.

    Article  PubMed  Google Scholar 

  56. Tokushige N, Markham R, Russell P, Fraser IS. Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis. Fertil Steril. 2008;90(5):1589–98.

    Article  PubMed  CAS  Google Scholar 

  57. Aghajanova L, Velarde MC, Giudice LC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010;28(1):51–8.

    Article  PubMed  CAS  Google Scholar 

  58. Aghajanova L, Tatsumi K, Horcajadas JA, et al. Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011;84(4):801–15.

    Article  PubMed  CAS  Google Scholar 

  59. Savaris RF, Groll JM, Young SL, et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab. 2011;96(6):1737–46.

    Article  PubMed  CAS  Google Scholar 

  60. Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(1):238–43.

    Article  PubMed  CAS  Google Scholar 

  61. Shono T. Molecular and anatomical studies of testicular descent. Hinyokika Kiyo. 2007;53(7):505–8.

    PubMed  Google Scholar 

  62. Bukulmez O, Hardy DB, Carr BR, Word RA, Mendelson CR. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology. 2008;149(3):1190–204.

    Article  PubMed  CAS  Google Scholar 

  63. Wang G, Tokushige N, Russell P, Dubinovsky S, Markham R, Fraser IS. Neuroendocrine cells in eutopic endometrium of women with endometriosis. Hum Reprod. 2010;25(2):387–91.

    Article  PubMed  CAS  Google Scholar 

  64. Wang G, Tokushige N, Fraser IS. Nerve fibers and menstrual cycle in peritoneal endometriosis. Fertil Steril. 2011;95(8):2772–4.

    Article  PubMed  Google Scholar 

  65. Tokushige N, Markham R, Russell P, Fraser IS. Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis. Fertil Steril. 2009;92(4):1234–9.

    Article  PubMed  CAS  Google Scholar 

  66. Maia Jr H, Casoy J, Pimentel K, et al. Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies. Contraception. 2008;78(6):479–85.

    Article  PubMed  CAS  Google Scholar 

  67. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78(4):699–704.

    Article  PubMed  Google Scholar 

  68. de Ziegler D, Gayet V, Aubriot FX, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril. 2010;94(7):2796–9.

    Article  PubMed  Google Scholar 

  69. Diaz I, Navarro J, Blasco L, Simon C, Pellicer A, Remohi J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril. 2000;74(1):31–4.

    Article  PubMed  CAS  Google Scholar 

  70. Cohen MA, Lindheim SR, Sauer MV. Hydrosalpinges adversely affect implantation in donor oocyte cycles. Hum Reprod. 1999;14(4):1087–9.

    Article  PubMed  CAS  Google Scholar 

  71. Strandell A, Lindhard A, Waldenstrom U, Thorburn J. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial. Hum Reprod. 2001;16(11):2403–10.

    PubMed  CAS  Google Scholar 

  72. Sagoskin AW, Lessey BA, Mottla GL, et al. Salpingectomy or proximal tubal occlusion of unilateral hydrosalpinx increases the potential for spontaneous pregnancy. Hum Reprod. 2003;18(12):2634–7.

    Article  PubMed  Google Scholar 

  73. Surrey ES, Schoolcraft WB. Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion. Fertil Steril. 2001;75(3):612–7.

    Article  PubMed  CAS  Google Scholar 

  74. Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PG. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril. 2010;93(4):1338–42.

    Article  PubMed  Google Scholar 

  75. Galen DI, Khan N, Richter KS. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Minim Invasive Gynecol. 2011;18(3):338–42.

    Article  PubMed  Google Scholar 

  76. Bodri D, Guillen JJ, Lopez M, Vernaeve V, Coll O. Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study. Hum Reprod. 2010;25(2):436–42.

    Article  PubMed  Google Scholar 

  77. Bellver J, Rossal LP, Bosch E, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003;79(5):1136–40.

    Article  PubMed  Google Scholar 

  78. Forman RG, Eychenne B, Nessmann C, Frydman R, Robel P. Assessing the early luteal phase in in vitro fertilization cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology. Fertil Steril. 1989;51(2):310–6.

    PubMed  CAS  Google Scholar 

  79. de Ziegler D, Frydman R, Bouchard P. Contribution of estrogen to the morphology of “secretory” endometrium? Fertil Steril. 1995;63(5):1135.

    PubMed  Google Scholar 

  80. de Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod. 1995;10(1):4–7.

    Article  PubMed  Google Scholar 

  81. Munro SK, Farquhar CM, Mitchell MD, Ponnampalam AP. Epigenetic regulation of endometrium during the menstrual cycle. Mol Hum Reprod. 2010;16(5):297–310.

    Article  PubMed  Google Scholar 

  82. Dobosy JR, Selker EU. Emerging connections between DNA methylation and histone acetylation. Cell Mol Life Sci. 2001;58(5–6):721–727.

    Article  PubMed  Google Scholar 

  83. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol. 2007;23(3):297–307.

    Article  PubMed  Google Scholar 

  84. Rakyan VK, Down TA, Thorne NP, et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008;18(9):1518–1529.

    Article  PubMed  Google Scholar 

  85. Roux F, Colome-Tatche M, Edelist C, et al. Genome-wide epigenetic perturbation jump-starts patterns of heritable variation found in nature. Genetics. 2011;188(4):1015–7.

    Article  PubMed  CAS  Google Scholar 

  86. Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm Cancer. 2010;1(3):146–55.

    Article  PubMed  CAS  Google Scholar 

  87. Saavedra I, Leon J, Prado J, Sanchez MP, Lopez F, Gaete L. A comparative pharmacokinetic study of micronized estradiol valerate administered alone and in combination with medroxyprogesterone acetate in postmenopausal women. Ther Drug Monit. 2004;26(5):482–5.

    Article  PubMed  CAS  Google Scholar 

  88. Lobo RA, Cassidenti DL. Pharmacokinetics of oral 17 beta-estradiol. J Reprod Med. 1992;37(1):77–84.

    PubMed  CAS  Google Scholar 

  89. Rohr UD, Altenburger R, Kissel T. Pharmacokinetics of the transdermal reservoir membrane system delivering beta-estradiol: in vitro/in vivo-correlation. Pharm Res. 1998;15(6):877–82.

    Article  PubMed  CAS  Google Scholar 

  90. Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biologic effects of transdermal estradiol. N Engl J Med. 1986;314(25):1615–20.

    Article  PubMed  CAS  Google Scholar 

  91. Brennan JJ, Lu Z, Whitman M, Stafiniak P, van der Hoop RG. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women. Ther Drug Monit. 2001;23(2):134–8.

    Article  PubMed  CAS  Google Scholar 

  92. de Ziegler D, de Mouzon J, Fauque P, et al. Multiplying recipients paired with oocyte donors optimizes the use of donated oocytes. Fertil Steril. 2011;95(5):1633–8.

    Article  PubMed  Google Scholar 

  93. Lopez LM, Grimes DA, Chen-Mok M, Westhoff C, Edelman A, Helmerhorst FM. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2010;(7):CD008452.

    Google Scholar 

  94. Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod. 1990;5(5):537–43.

    PubMed  CAS  Google Scholar 

  95. Fatemi HM, Bourgain C, Donoso P, et al. Effect of oral administration of dydrogesterone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod. 2007;22(5):1260–3.

    Article  PubMed  CAS  Google Scholar 

  96. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2011;(10):CD009154.

    Google Scholar 

  97. Toner JP. Vaginal delivery of progesterone in donor oocyte therapy. Hum Reprod. 2000;15 Suppl 1:166–71.

    Article  PubMed  CAS  Google Scholar 

  98. Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril. 1994;62(3):485–90.

    PubMed  CAS  Google Scholar 

  99. Cicinelli E, de Ziegler D, Bulletti C, Matteo MG, Schonauer LM, Galantino P. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95(3):403–6.

    Article  PubMed  CAS  Google Scholar 

  100. Cicinelli E, de Ziegler D. Transvaginal progesterone: evidence for a new functional ‘portal system’ flowing from the vagina to the uterus. Hum Reprod Update. 1999;5(4):365–72.

    Article  PubMed  CAS  Google Scholar 

  101. Cicinelli E, De Ziegler D, Morgese S, Bulletti C, Luisi D, Schonauer LM. “First uterine pass effect” is observed when estradiol is placed in the upper but not lower third of the vagina. Fertil Steril. 2004;81(5):1414–6.

    Article  PubMed  Google Scholar 

  102. Cicinelli E, Rubini G, De Ziegler D, et al. Absorption and preferential vagina-to-uterus distribution after ­vaginal administration of (99m)Tc-pertechnetate in postmenopausal women. Fertil Steril. 2001;76(6):1108–12.

    Article  PubMed  CAS  Google Scholar 

  103. Penzias AS, Alper MM. Luteal support with vaginal micronized progesterone gel in assisted reproduction. Reprod Biomed Online. 2003;6(3):287–95.

    Article  PubMed  CAS  Google Scholar 

  104. Blake EJ, Norris PM, Dorfman SF, Longstreth J, Yankov VI. Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects. Fertil Steril. 2010;94(4):1296–301.

    Article  PubMed  CAS  Google Scholar 

  105. Zoppetti G, Puppini N, Ospitali F, Fini A. Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture. J Pharm Sci. 2007;96(7):1729–36.

    Article  PubMed  CAS  Google Scholar 

  106. Remohi J, Gutierrez A, Cano F, Ruiz A, Simon C, Pellicer A. Long oestradiol replacement in an oocyte donation programme. Hum Reprod. 1995;10(6): 1387–91.

    Article  PubMed  CAS  Google Scholar 

  107. Remohi J, Gallardo E, Guanes PP, Simon C, Pellicer A. Donor-recipient synchronization and the use of gonadotrophin-releasing hormone agonists to avoid the premature luteinizing hormone surge in oocyte donation. Hum Reprod. 1995;10 Suppl 2:84–90.

    Article  PubMed  CAS  Google Scholar 

  108. Gibbons WE, Cedars M, Ness RB. Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis. Fertil Steril. 2011;95(5):1645–9.e1.

    Article  PubMed  Google Scholar 

  109. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10(5):268–73.

    Article  PubMed  CAS  Google Scholar 

  110. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25(9):2239–46.

    Article  PubMed  Google Scholar 

  111. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009;27(6):450–5.

    Article  PubMed  CAS  Google Scholar 

  112. Devroey P, Pados G. Preparation of endometrium for egg donation. Hum Reprod Update. 1998;4(6):856–61.

    Article  PubMed  CAS  Google Scholar 

  113. Blockeel C, Van Vaerenbergh I, Fatemi HM, Van Lommel L, Devroey P, Bourgain C. Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase. Mol Hum Reprod. 2011;17(1):33–41.

    Article  PubMed  CAS  Google Scholar 

  114. Jones GS. The luteal phase defect. Fertil Steril. 1976;27(4):351–6.

    PubMed  CAS  Google Scholar 

  115. Jones GS. Luteal phase defect: a review of pathophysiology. Curr Opin Obstet Gynecol. 1991;3(5):641–8.

    Article  PubMed  CAS  Google Scholar 

  116. Rizner TL, Brozic P, Doucette C, et al. Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids. 2011;76(6):607–15.

    Article  PubMed  CAS  Google Scholar 

  117. Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol. 2005;97(5):416–20.

    Article  PubMed  CAS  Google Scholar 

  118. Gonen Y, Casper RF, Jacobson W, Blankier J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril. 1989;52(3):446–50.

    PubMed  CAS  Google Scholar 

  119. Jones NW, Raine-Fenning NJ, Jayaprakasan K, Mousa HA, Taggart MJ, Bugg GJ. Changes in myometrial ‘perfusion’ during normal labor as visualized by three-dimensional power Doppler angiography. Ultrasound Obstet Gynecol. 2009;33(3):307–12.

    Article  PubMed  CAS  Google Scholar 

  120. Jones NW, Raine-Fenning N, Mousa H, Bradley E, Bugg G. Evaluation of the intraobserver and interobserver reliability of data acquisition for three-­dimensional power Doppler angiography of the whole placenta at 12 weeks gestation. Ultrasound Med Biol. 2010;36(9):1405–11.

    Article  PubMed  Google Scholar 

  121. de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril. 1991;55(4):775–9.

    PubMed  Google Scholar 

  122. Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS, Johnson IR. Quantifying the changes in endometrial vascularity throughout the normal menstrual cycle with three-dimensional power Doppler angiography. Hum Reprod. 2004;19(2):330–8.

    Article  PubMed  CAS  Google Scholar 

  123. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Comparison of endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound between stimulated and natural cycles in the same patients. Hum Reprod. 2004;19(10):2385–90.

    Article  PubMed  Google Scholar 

  124. Ng EH, Chan CC, Yeung WS, Ho PC. Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility. Hum Reprod. 2004;19(9):2132–7.

    Article  PubMed  Google Scholar 

  125. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Endometrial and subendometrial blood flow measured during early luteal phase by three-dimensional power Doppler ultrasound in excessive ovarian responders. Hum Reprod. 2004;19(4):924–31.

    Article  PubMed  Google Scholar 

  126. Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS, Johnson IR. Endometrial and subendometrial perfusion are impaired in women with unexplained subfertility. Hum Reprod. 2004;19(11):2605–14.

    Article  PubMed  CAS  Google Scholar 

  127. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozen-thawed embryo transfer cycles. Hum Reprod. 2006;21(6):1612–7.

    Article  PubMed  Google Scholar 

  128. de Ziegler D, Bulletti C, Fanchin R, Epiney M, Brioschi PA. Contractility of the nonpregnant uterus: the follicular phase. Ann N Y Acad Sci. 2001;943:172–84.

    Article  PubMed  Google Scholar 

  129. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998;13(7):1968–74.

    Article  PubMed  CAS  Google Scholar 

  130. Meldrum DR, Chang RJ, de Ziegler D, Schoolcraft WB, Scott Jr RT, Pellicer A. Adjuncts for ovarian stimulation: when do we adopt “orphan indications” for approved drugs? Fertil Steril. 2009;92(1):13–8.

    Article  PubMed  CAS  Google Scholar 

  131. Germeyer A, Jauckus J, Zorn M, Toth B, Capp E, Strowitzki T. Metformin modulates IL-8, IL-1beta, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reprod Biomed Online. 2011;22(4):327–34.

    Article  PubMed  CAS  Google Scholar 

  132. Takemura Y, Osuga Y, Yoshino O, et al. Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab. 2007;92(8):3213–8.

    Article  PubMed  CAS  Google Scholar 

  133. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009;24(3):608–18.

    Article  PubMed  CAS  Google Scholar 

  134. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2):277–85.

    Article  PubMed  Google Scholar 

  135. Escriba MJ, Bellver J, Bosch E, Sanchez M, Pellicer A, Remohi J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertil Steril. 2006;86(1):92–7.

    Article  PubMed  CAS  Google Scholar 

  136. de Ziegler D, Streuli I, Meldrum DR, Chapron C. The value of growth hormone supplements in ART for poor ovarian responders. Fertil Steril. 2011;96(5):1069–76.

    Article  PubMed  CAS  Google Scholar 

  137. Coticchio G, Bonu MA, Sciajno R, Sereni E, Bianchi V, Borini A. Truths and myths of oocyte sensitivity to controlled rate freezing. Reprod Biomed Online. 2007;15(1):24–30.

    Article  PubMed  CAS  Google Scholar 

  138. Cobo A, Remohi J, Chang CC, Nagy ZP. Oocyte cryopreservation for donor egg banking. Reprod Biomed Online. 2011;23(3):341–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dominique de Ziegler M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

de Ziegler, D., Streuli, I., Marszalek, A., Gayet, V., Chapron, C. (2013). Preparing the Endometrium to Maximize Success: The Dynamics of Artificial Cycles. In: Sauer, M. (eds) Principles of Oocyte and Embryo Donation. Springer, London. https://doi.org/10.1007/978-1-4471-2392-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2392-7_9

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2391-0

  • Online ISBN: 978-1-4471-2392-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics